IRM vs MIRA · P/E 136, rev $3.97B vs $41.1M cap
Iron Mountain Incorporated (IRM) versus MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
MIRA does not have a complete income-statement cache yet.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. MIRA currently screens at market cap $41.1M.
Not investment advice. Open the IRM and MIRA stock pages for the full models.
Not investment advice.